Christine Siu

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Siu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 30,700 13 Jun 2025 Direct

Insider Reports Filed by Christine Siu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:05
GLUE Monte Rosa Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:30
GLUE Monte Rosa Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:28
GLUE Monte Rosa Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:32
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 Director 23 Jun 2021, 20:54
GLUE Monte Rosa Therapeutics, Inc. 12 Apr 2021 2 $0 4 Director 25 Jun 2021, 17:01